Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes - Top-Institutions - MDSpire

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

Preet M. Chaudhary, MD, PhD, discusses the repeat ranking of the USC Norris Blood and Marrow Transplant and Cell Therapy Program as one of the nation’s elite allogeneic transplant programs with the highest survival outcomes.

  • By

  • February 13, 2026

  • 12 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    USC Norris Blood and Marrow Transplant and Cell Therapy Program
    USC Norris Blood and Marrow Transplant and Cell Therapy Program

    Los Angeles, CA

    Key Differentiators

    • Bone Marrow Transplantation
    • Hematology
    • Oncology

  • #2

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Bone Marrow Transplantation
    • Hematology
    • Oncology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Bone Marrow Transplantation
    • Hematology
    • Oncology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Bone Marrow Transplantation
    • Hematology
    • Oncology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Bone Marrow Transplantation
    • Hematology
    • Oncology

Original Source(s)

Bone Marrow Transplant: How Keck Medicine of USC Is Excelling in Survival Outcomes

  • by

  • February 13, 2026

Related Content

The First NCI-Designated Comprehensive Cancer Center Using 3D Genomics Testing to Diagnose Lymphoma and Sarcoma—a True Game Changer

Diagnosing lymphoma and sarcoma can be extraordinarily complex, with more than 70 recognized subtypes of lymphoma and more than 100 distinct types of sarcoma. Many subtypes share similar features yet behave in dramatically different ways in standard testing, leaving oncologists with diagnostic quandaries and delays to treatment.

  • by

  • February 24, 2026

  • 4 min
Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review

Creation and internal assessment of a nomogram tailored for lymphoma to forecast venous thromboembolism risk: analysis of a retrospective cohort comprising 790 patients